Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
iScience ; 23(6): 101240, 2020 Jun 26.
Artículo en Inglés | MEDLINE | ID: mdl-32563157

RESUMEN

Individuals with the neuropsychiatric disorder mania exhibit hyperactivity, elevated mood, and a decreased need for sleep. The brain areas and neuronal populations involved in mania-like behaviors, however, have not been elucidated. In this study, we found that ablating the ventral medial midbrain/pons (VMP) GABAergic neurons induced mania-like behaviors in mice, including hyperactivity, anti-depressive behaviors, reduced anxiety, increased risk-taking behaviors, distractibility, and an extremely shortened sleep time. Strikingly, these mice also showed no rebound sleep after sleep deprivation, suggesting abnormal sleep homeostatic regulation. Dopamine D2 receptor deficiency largely abolished the sleep reduction induced by ablating the VMP GABAergic neurons without affecting the hyperactivity and anti-depressive behaviors. Our data demonstrate that VMP GABAergic neurons are involved in the expression of mania-like behaviors, which can be segregated to the short-sleep and other phenotypes on the basis of the dopamine D2 receptors.

2.
J Neurosci ; 38(47): 10080-10092, 2018 11 21.
Artículo en Inglés | MEDLINE | ID: mdl-30282729

RESUMEN

Sleep-wake behavior is controlled by a wide range of neuronal populations in the mammalian brain. Although the ventral midbrain/pons (VMP) area is suggested to participate in sleep-wake regulation, the neuronal mechanisms have remained unclear. Here, we found that nonspecific cell ablation or selective ablation of GABAergic neurons by expressing diphtheria toxin fragment A in the VMP in male mice induced a large increase in wakefulness that lasted at least 4 weeks. In contrast, selective ablation of dopaminergic neurons in the VMP had little effect on wakefulness. Chemogenetic inhibition of VMP GABAergic neurons also markedly increased wakefulness. The wake-promoting effect of the VMP GABAergic neuron ablation or inhibition was attenuated to varying degrees by the administration of dopamine D1 or D2/3 receptor antagonists and abolished by the administration of both antagonists together. In contrast, chemogenetic activation of VMP GABAergic neurons very strongly increased slow-wave sleep and reduced wakefulness. These findings suggest that VMP GABAergic neurons regulate dopaminergic actions in the sleep-wake behavior of mice.SIGNIFICANCE STATEMENT Current understanding of the neuronal mechanisms and populations that regulate sleep-wake behavior is incomplete. Here, we identified a GABAergic ventral midbrain/pons area that is necessary for controlling the daily amount of sleep and wakefulness in mice. We also found that these inhibitory neurons control wakefulness by suppressing dopaminergic systems. Surprisingly, activation of these neurons strongly induced slow-wave sleep while suppressing wakefulness. Our study reveals a new brain mechanism critical for sleep-wake regulation.


Asunto(s)
Neuronas GABAérgicas/fisiología , Mesencéfalo/fisiología , Puente/fisiología , Sueño/fisiología , Vigilia/fisiología , Animales , Antagonistas de Dopamina/farmacología , Electroencefalografía/métodos , Neuronas GABAérgicas/efectos de los fármacos , Masculino , Mesencéfalo/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Puente/efectos de los fármacos , Sueño/efectos de los fármacos , Vigilia/efectos de los fármacos
3.
Nat Commun ; 8(1): 734, 2017 09 29.
Artículo en Inglés | MEDLINE | ID: mdl-28963505

RESUMEN

Sleep control is ascribed to a two-process model, a widely accepted concept that posits homoeostatic drive and a circadian process as the major sleep-regulating factors. Cognitive and emotional factors also influence sleep-wake behaviour; however, the precise circuit mechanisms underlying their effects on sleep control are unknown. Previous studies suggest that adenosine has a role affecting behavioural arousal in the nucleus accumbens (NAc), a brain area critical for reinforcement and reward. Here, we show that chemogenetic or optogenetic activation of excitatory adenosine A2A receptor-expressing indirect pathway neurons in the core region of the NAc strongly induces slow-wave sleep. Chemogenetic inhibition of the NAc indirect pathway neurons prevents the sleep induction, but does not affect the homoeostatic sleep rebound. In addition, motivational stimuli inhibit the activity of ventral pallidum-projecting NAc indirect pathway neurons and suppress sleep. Our findings reveal a prominent contribution of this indirect pathway to sleep control associated with motivation.In addition to circadian and homoeostatic drives, motivational levels influence sleep-wake cycles. Here the authors demonstrate that adenosine receptor-expressing neurons in the nucleus accumbens core that project to the ventral pallidum are inhibited by motivational stimuli and are causally involved in the control of slow-wave sleep.


Asunto(s)
Núcleo Accumbens/fisiología , Sueño/fisiología , Animales , Ritmo Circadiano , Femenino , Masculino , Ratones , Ratones Endogámicos C57BL , Motivación , Técnicas de Placa-Clamp , Proteínas Proto-Oncogénicas c-fos/metabolismo , Receptor de Adenosina A2A/metabolismo , Receptor de Adenosina A2A/fisiología
4.
Brain Struct Funct ; 222(6): 2907-2915, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28124114

RESUMEN

A growing body of evidence suggests that dopamine plays a role in sleep-wake regulation, but the dopamine-producing brain areas that control sleep-wake states are unclear. In this study, we chemogenetically activated dopamine neurons in the ventral midbrain of mice to examine the role of these neurons in sleep-wake regulation. We found that activation of dopamine neurons in the ventral tegmental area (VTA), but not in the substantia nigra, strongly induced wakefulness, although both cell populations expressed the neuronal activity marker c-Fos after chemogenetic stimulation. Analysis of the pattern of behavioral states revealed that VTA activation increased the duration of wakefulness and decreased the number of wakefulness episodes, indicating that wakefulness was consolidated by VTA activation. The increased wakefulness evoked by VTA activation was completely abolished by pretreatment with the dopamine D2/D3 receptor antagonist raclopride, but not by the D1 receptor antagonist SCH23390. These findings indicate that the activation of VTA dopamine neurons promotes wakefulness via D2/D3 receptors.


Asunto(s)
Neuronas Dopaminérgicas/metabolismo , Receptores de Dopamina D2/metabolismo , Área Tegmental Ventral/metabolismo , Vigilia , Animales , Conducta Animal/efectos de los fármacos , Antagonistas de los Receptores de Dopamina D2/farmacología , Proteínas de Transporte de Dopamina a través de la Membrana Plasmática/deficiencia , Proteínas de Transporte de Dopamina a través de la Membrana Plasmática/genética , Neuronas Dopaminérgicas/efectos de los fármacos , Electroencefalografía , Electromiografía , Genotipo , Ratones Noqueados , Fenotipo , Proteínas Proto-Oncogénicas c-fos/metabolismo , Receptores de Dopamina D3/metabolismo , Sustancia Negra/efectos de los fármacos , Sustancia Negra/metabolismo , Factores de Tiempo , Área Tegmental Ventral/efectos de los fármacos , Vigilia/efectos de los fármacos
5.
Elife ; 52016 12 06.
Artículo en Inglés | MEDLINE | ID: mdl-27919319

RESUMEN

Rapid eye movement (REM) sleep loss is associated with increased consumption of weight-promoting foods. The prefrontal cortex (PFC) is thought to mediate reward anticipation. However, the precise role of the PFC in mediating reward responses to highly palatable foods (HPF) after REM sleep deprivation is unclear. We selectively reduced REM sleep in mice over a 25-48 hr period and chemogenetically inhibited the medial PFC (mPFC) by using an altered glutamate-gated and ivermectin-gated chloride channel that facilitated neuronal inhibition through hyperpolarizing infected neurons. HPF consumption was measured while the mPFC was inactivated and REM sleep loss was induced. We found that REM sleep loss increased HPF consumption compared to control animals. However, mPFC inactivation reversed the effect of REM sleep loss on sucrose consumption without affecting fat consumption. Our findings provide, for the first time, a causal link between REM sleep, mPFC function and HPF consumption.


Asunto(s)
Regulación del Apetito , Corteza Prefrontal/fisiología , Sueño REM , Sacarosa/metabolismo , Edulcorantes/metabolismo , Animales , Canales de Cloruro/genética , Canales de Cloruro/metabolismo , Glutamatos/metabolismo , Ivermectina/metabolismo , Masculino , Ratones Endogámicos C57BL , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo
6.
J Vis Exp ; (107): e53678, 2016 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-26863349

RESUMEN

Recording of the epidural electroencephalogram (EEG) and electromyogram (EMG) in small animals, like mice and rats, has been pivotal to study the homeodynamics and circuitry of sleep-wake regulation. In many laboratories, a cable-based sleep recording system is used to monitor the EEG and EMG in freely behaving mice in combination with computer software for automatic scoring of the vigilance states on the basis of power spectrum analysis of EEG data. A description of this system is detailed herein. Steel screws are implanted over the frontal cortical area and the parietal area of 1 hemisphere for monitoring EEG signals. In addition, EMG activity is monitored by the bilateral placement of wires in both neck muscles. Non-rapid eye movement (Non-REM; NREM) sleep is characterized by large, slow brain waves with delta activity below 4 Hz in the EEG, whereas a shift from low-frequency delta activity to a rapid low-voltage EEG in the theta range between 6 and 10 Hz can be observed at the transition from NREM to REM sleep. By contrast, wakefulness is identified by low- to moderate-voltage brain waves in the EEG trace and significant EMG activity.


Asunto(s)
Electroencefalografía/métodos , Electromiografía/métodos , Sueño/fisiología , Algoritmos , Animales , Encéfalo/fisiología , Electrodos Implantados , Análisis de Fourier , Masculino , Ratones , Ratones Endogámicos C57BL , Ratas , Sueño REM/fisiología , Vigilia/fisiología
7.
Pharmacol Biochem Behav ; 133: 164-73, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25895691

RESUMEN

Caffeine, a popular psychoactive compound, promotes wakefulness via blocking adenosine A2A receptors in the shell of the nucleus accumbens, which projects to the arousal histaminergic tuberomammillary nucleus (TMN). The TMN controls several behaviors such as wakefulness and feeding. Fasting has been reported to activate the TMN histaminergic neurons to increase arousal. Therefore, we propose that caffeine may promote greater arousal under fasting rather than normal feeding conditions. In the current study, locomotor activity recording, electroencephalogram (EEG) and electromyogram recording and c-Fos expression were used in wild type (WT) and histamine H1 receptor (H1R) knockout (KO) mice to investigate the arousal effects of caffeine under fasting conditions. Caffeine (15mg/kg) enhanced locomotor activity in fasted mice for 5h, but only did so for 3h in normally fed animals. Pretreatment with the H1R antagonist pyrilamine abolished caffeine-induced stimulation on locomotor activity in fasted mice. EEG recordings confirmed that caffeine-induced wakefulness for 3h in fed WT mice, and for 5h in fasted ones. A stimulatory effect of caffeine was not observed in fasted H1R KO mice. Furthermore, c-Fos expression was increased in the TMN under fasting conditions. These results indicate that caffeine had greater wakefulness-promoting effects in fasted mice through the mediation of H1R.


Asunto(s)
Nivel de Alerta/efectos de los fármacos , Cafeína/farmacología , Ayuno/fisiología , Neuronas/metabolismo , Receptores Histamínicos H1/metabolismo , Animales , Cafeína/antagonistas & inhibidores , Antagonistas de los Receptores Histamínicos H1/farmacología , Área Hipotalámica Lateral/citología , Área Hipotalámica Lateral/efectos de los fármacos , Área Hipotalámica Lateral/metabolismo , Masculino , Ratones , Ratones Noqueados , Actividad Motora/efectos de los fármacos , Neuronas/efectos de los fármacos , Proteínas Proto-Oncogénicas c-fos/metabolismo , Pirilamina/farmacología , Receptores Histamínicos H1/deficiencia , Receptores Histamínicos H1/genética , Sueño/efectos de los fármacos , Vigilia/efectos de los fármacos
8.
Pharmacol Biochem Behav ; 129: 56-64, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25498564

RESUMEN

Histaminergic neurons have been reported to play an important role in the regulation of sleep-wake behavior through the histamine H1 receptor (R, H1R). First generation H1R antagonists, such as doxepin and diphenhydramine, produce drowsiness in humans, and are occasionally used to treat insomnia. However, if H1R antagonists function via physically blocking the H1R remains unclear. In the current study, we used H1R knockout (KO) mice to investigate if the sleep-promoting effects of doxepin and diphenhydramine are dependent on blockade of the H1R. When doxepin was administered, non-rapid eye movement (NREM) sleep in wild type (WT) mice increased for 4h, with an increase in the numbers of NREM sleep bouts of 256-512 s and 512-1024 s. These effects were not observed in the H1R KO mice. Furthermore, diphenhydramine increased NREM sleep for 6h in WT, and not in the H1R KO mice after the injection. These results indicate that both doxepin at 15 mg/kg and diphenhydramine at 10 mg/kg induce NREM sleep through blockade of H1R.


Asunto(s)
Difenhidramina/farmacología , Doxepina/farmacología , Movimientos Oculares/efectos de los fármacos , Antagonistas de los Receptores Histamínicos H1/farmacología , Sueño/efectos de los fármacos , Animales , Electroencefalografía , Electromiografía , Masculino , Ratones , Ratones Noqueados , Polisomnografía
9.
Psychopharmacology (Berl) ; 231(14): 2825-37, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24488362

RESUMEN

RATIONALE: In psychopharmacology, researchers have been interested in the hypnotic effects of terrestrial plant polyphenols and their synthetic derivatives. Phlorotannins, a marine plant polyphenol, could have potential as a source of novel hypnotic drugs. OBJECTIVES: The effects of phlorotannins and major phlorotannin constituent eckstolonol on sleep-wake profiles in mice were evaluated in comparison with diazepam, and their hypnotic mechanism was also investigated. METHODS: The effects of phlorotannin preparation (PRT) and eckstolonol orally given on sleep-wake profiles were measured by recording electroencephalograms (EEG) and electromyograms in C57BL/6N mice. Flumazenil, a GABAA-benzodiazepine (BZD) receptor antagonist, was injected 15 min before PRT and eckstolonol to reveal its hypnotic mechanism. RESULTS: PRT administration (>250 mg/kg) produced a significant decrease in sleep latency and an increase in the amount of non-rapid eye movement sleep (NREMS). Eckstolonol significantly decreased sleep latency (>12.5 mg/kg) and increased the amount of NREMS (50 mg/kg). PRT and eckstolonol had no effect on EEG power density of NREMS. The hypnotic effects of PRT or eckstolonol were completely abolished by pretreatment with flumazenil. CONCLUSIONS: We demonstrated that phlorotannins promote NREMS by modulating the BZD site of the GABAA receptor. These results suggest that phlorotannins can be potentially used as an herbal medicine for insomnia and as a promising structure for developing novel sedative-hypnotics.


Asunto(s)
Polifenoles/farmacología , Receptores de GABA-A/efectos de los fármacos , Sueño/efectos de los fármacos , Taninos/farmacología , Animales , Diazepam/farmacología , Dioxanos/administración & dosificación , Dioxanos/farmacología , Relación Dosis-Respuesta a Droga , Electroencefalografía , Flumazenil/farmacología , Compuestos Heterocíclicos de 4 o más Anillos/administración & dosificación , Compuestos Heterocíclicos de 4 o más Anillos/farmacología , Hipnóticos y Sedantes/farmacología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos ICR , Polifenoles/administración & dosificación , Receptores de GABA-A/metabolismo , Taninos/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...